House Research Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.hei.org
Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 3
1 (33.3%)Feasibility Study of Auditory Brainstem Implant in Young Children
Phase 1
Withdrawn
- Conditions
- Bilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- House Research Institute
- Registration Number
- NCT01850225
- Locations
- 🇺🇸
House Research Institute CARE Center, Los Angeles, California, United States
Intratympanic Injection for Autoimmune Inner Ear Disease
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- House Research Institute
- Target Recruit Count
- 16
- Registration Number
- NCT01526174
Famvir for Treatment of Hearing in Unilateral Meniere's Disease
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- House Research Institute
- Target Recruit Count
- 11
- Registration Number
- NCT01526408
News
No news found